Minnesota SF2852 modifies the scope of optometry practice to include certain drug prescriptions and treatments.
Minnesota SF2852 amends the definition of optometry practice to include prescribing legend drugs for diagnosis, cure, mitigation, prevention, treatment, or management of diseases. It also allows optometrists to administer or prescribe Schedule II and III oral legend drugs and oral steroids, oral antivirals for more than ten days, and oral carbonic anhydrase inhibitors for more than seven days. The bill restricts the administration of legend drugs intravenously, intramuscularly, or by injection, except for anaphylaxis treatment, and prohibits invasive surgery, including laser surgery.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.